AKTS logo

AKTS
Akoustis Technologies Inc

3,035
Mkt Cap
$1.05B
Volume
375,471.00
52W High
$29.16
52W Low
$0.0372
Price
$16.37
AKTS Fundamentals
Prev Close
$17.37
Open
$17.25
50D MA
$19.00
Beta
4.11
Avg. Volume
519,451.65
EPS (Annual)
-$1.19
P/B
-5.98
Rev/Employee
$82,240.51
Loading...
Loading...
News
all
press releases
Aktis Oncology (NASDAQ:AKTS) Shares Down 3.7% - Here's Why
Aktis Oncology (NASDAQ:AKTS) Stock Price Down 3.7% - Time to Sell...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Receives Consensus Rating of "Buy" from Analysts
Shares of Aktis Oncology (NASDAQ:AKTS - Get Free Report) have been given an average rating of "Buy" by the five analysts that are presently covering the stock, MarketBeat Ratings reports. Five...
MarketBeat·4d ago
News Placeholder
Q1 EPS Estimates for Aktis Oncology Boosted by HC Wainwright
Aktis Oncology (NASDAQ:AKTS - Free Report) - Investment analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for Aktis Oncology in a research report issued to clients...
MarketBeat·5d ago
News Placeholder
HC Wainwright Comments on Aktis Oncology Q1 Earnings
Aktis Oncology (NASDAQ:AKTS - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 EPS estimates for shares of Aktis Oncology in a research note issued on Tuesday, March 31st. HC...
MarketBeat·6d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Given New $33.00 Price Target at HC Wainwright
HC Wainwright boosted their price objective on Aktis Oncology from $30.00 to $33.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·7d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Stock Price Up 5.4% - Time to Buy?
Aktis Oncology (NASDAQ:AKTS) Trading Up 5.4% - Should You Buy...
MarketBeat·7d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Sets New 1-Year Low - What's Next?
Aktis Oncology (NASDAQ:AKTS) Reaches New 12-Month Low - What's Next...
MarketBeat·11d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Stock Price Passes Below 50-Day Moving Average - Should You Sell?
Aktis Oncology (NASDAQ:AKTS) Stock Price Crosses Below 50-Day Moving Average - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Stock Price Up 7.2% - Here's What Happened
Aktis Oncology (NASDAQ:AKTS) Trading 7.2% Higher - Should You Buy...
MarketBeat·21d ago
News Placeholder
Aktis Oncology Unveils Miniprotein Radiopharma Platform, Highlights Nectin-4 and B7-H3 Programs
Aktis Oncology (NASDAQ:AKTS) executives outlined the company's strategy to expand the use of targeted radiopharmaceuticals beyond the limited set of currently approved products, emphasizing a novel...
MarketBeat·28d ago
<
1
2
...
>

Latest AKTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.